Cc1ccc2nc(O)c(CN(C(=O)c3cccc([N+](=O)[O-])c3)C(C)(C)C)cc2c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?